⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TEVA News
Teva Pharmaceutical Industries Limited American Depositary Shares
Capecitabine Market Outlook 2026-2030 Shows 9% CAGR as Innovations in Therapies and Homecare Treatment Adoption Accelerate Industry Growth
globenewswire.com
TEVA
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab)
globenewswire.com
TEVA
$28+ Billion Cancer Supportive Care Products Market Outlook Report, 2030
globenewswire.com
JNJ
MRK
ABBV
ABT
NVS
GSK
AMGN
TEVA
JAGX
LLY
Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
globenewswire.com
ABBV
AZN
BIIB
BMY
GSK
LLY
MRK
NVS
SNY
TEVA
UCB
EIB Waives its Right to Cash Settlement on Medincell Warrants
businesswire.com
TEVA
La BEI renonce à son droit au règlement en cash de ses BSA Medincell
businesswire.com
TEVA
Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)
globenewswire.com
TEVA
EPRI Launches Flex MOSAIC to Reduce ‘Time to Power’ for Data Centers
globenewswire.com
GOOGL
NVDA
EXC
DTE
LNT
SO
PCG
EIX
PNW
ETR
PPL
SRE
CMS
NI
AEP
XEL
LUV
HON
SI
LIN
PEG
ECL
FE
WEC
NRG
ED
ES
MDU
NE
UTL
CWEN
BEP
TER
MAS
AMAT
MU
INTC
AMD
CDNS
SNPS
VRTX
GILD
AMGN
BIIB
REGN
AZN
NVS
PFE
MRK
JNJ
ABBV
BMY
LLY
TEVA
BCE
CVE
CP
RY
TD
BNS
CM
CNQ
SU
BHP
RIO
VAL
FCX
AA
STLD
CF
MOS
NTR
ADM
BG
CARR
EMR
GOOG
META
S
VZ
T
TMUS
CCI
AMT
EQIX
DLR
IBM
MSFT
AMZN
CSCO
LRCX
KLAC
ADI
TXN
ON
NXPI
INFY
CTSH
ACN
Teva Releases Q1 2026 Aide Memoire
globenewswire.com
TEVA
Teva to Host Conference Call to Discuss First Quarter 2026 Financial Results at 8 a.m. ET on April 29, 2026
globenewswire.com
TEVA